Allentown, a provider in life science solutions, agreed to acquire ClorDiSys, a decontamination equipment and services. Financial terms were not disclosed. "Being acquired by Allentown is exactly what we needed to broaden our reach and make our services available to many more research institutions and adjacent industries. We want to lead the world and be the catalyst of driving a better and healthier process and shift away from Ethylene Oxide for medical device sterilization and into ClorDiSys' chlorine dioxide gas sterilization technology. ClorDiSys is quickly expanding into the medical device sterilization market, tripling the number of locations utilizing our technology in the last year alone. Unlike EtO, our process is more efficient, non-carcinogenic, non-explosive, and greatly reduces the impact on the environment," Paul Lorcheim, ClorDiSys Director and Co-Founder.